Be An Advocate - Kidney Cancer Association

Donate Toggle Menu

Step 1 of 2

Name*
First Last
Email*
Address*
Street Address City State Zip Code

04/23/2024

RE: Support Kidney Cancer Research Funding

The Honorable Kay Granger
Chairwoman
Committee on Appropriations
U.S. House of Representatives
H-307 The Capitol
Washington, DC 20515

Dear Chairwoman Granger,

My name is John Doe from Anytown, VA. I write to thank you and the whole Committee on Appropriations for your continued support for the Congressionally Directed Medical Research Programs (CDMRP) by which the Kidney Cancer Research Program (KCRP) is funded. The groundbreaking research that results from the KCRP gives many like myself hope that we can soon unlock the cure for kidney cancer.
Personalize message
Kidney cancer is one of the ten most common cancers in the US. According to the American Cancer Society, over half a million people in the US live with this disease and 82,000 people will be newly diagnosed in 2023. Sadly, nearly 15,000 people are expected to die of kidney cancer this year. Advancing kidney cancer research to develop new and better treatment options for everyone remains an urgent priority.

The Committee on Appropriations has recognized our community’s needs in the past. Since 2016, Congress has allocated $135 million in funding for research to better understand kidney cancer and identify new treatments and potential cures.

Support like this resulted in tremendous gains for the kidney cancer community. Thirty years ago, people diagnosed with kidney cancer had no treatment options and a bleak future. Today, there are over a dozen approved treatments and clinical trials expand patients’ options even more. Research on a kidney cancer-causing gene was the genesis of the discovery about how our cells adapt to their environment that won two American physician-scientists a 2019 Nobel Prize in Physiology or Medicine and could change how many cancers are treated.

Despite these advances and CDMRP and National Institutes of Health (NIH) funding, kidney cancer remains all too common and deadly.

Your commitment to addressing the burdens of kidney cancer on people like me through robust, sustained research funding is vital for providing access to effective care, support, and hope. For Fiscal Year (FY) 2024 appropriations, I encourage you to provide the following in funding for key agencies and programs supporting kidney cancer research:
- •$60 million for the KCRP*
- •$51 billion for the NIH
- •at least 1.5 billion for the Advanced Research Projects Agency– Health (ARPA-H)
*the KCRP was designated at $50 million in FY23

In addition, we ask that you do everything in your power to stand strong on behalf of the kidney cancer community and continue promoting federal investments in research, as well as incorporating patient perspectives in legislative policy matters, particularly those that promote clinical trial development, diversity in clinical trial enrollment, and accelerating cures.

Thank you for your years of service. I am grateful for the work of this Committee and hope that you continue to give this matter your full consideration.

Sincerely,

John Doe

Example 123 Street
Anytown, VA 00000
Email
This field is for validation purposes and should be left unchanged.